Cigna and Aetna list PRP as experimental or unproven, and Medicare’s national policy names wounds, not joints, hair, or skin. Plan documents can differ, so the written policy for your own plan decides.
This guide examines what major commercial carriers publish in their official coverage bulletins, explains the narrow surgical exception, and outlines the self-pay prices to expect.
Does Insurance Cover PRP Injections? The Direct Answer
Cigna lists PRP as experimental, investigational, or unproven for any condition, and Aetna lists autologous platelet-rich plasma in its experimental, investigational, or unproven section. Medicare’s national policy, issued by the Centers for Medicare & Medicaid Services (CMS), names chronic non-healing diabetic wounds, not joints, tendons, hair, or skin. If you are quoted a price for PRP for knee osteoarthritis, tennis elbow, or hair loss, plan to pay it yourself unless your plan confirms otherwise in writing.
Platelet-rich plasma (PRP) is prepared from a small sample of your own blood, which a clinician spins in a centrifuge to concentrate the platelets. The U.S. Food and Drug Administration (FDA) has not approved PRP as a therapy for joints, hair, or skin. Our guide to FDA status for regenerative medicine explains what that means for clinics.
Insurers that classify a treatment as experimental or investigational typically exclude it as not medically necessary, so a claim for it is denied regardless of the billing code. More detail on commercial payer rules appears in our general overview of insurance coverage for biologics.
What Cigna’s Written Policy Says
According to Cigna Medical Coverage Policy 0507, titled “Autologous Platelet-Derived Growth Factors (Platelet-Rich Plasma [PRP])”, the use of autologous platelet-derived growth factors for any condition or indication is considered experimental, investigational, or unproven. This policy covers billing codes including Current Procedural Terminology (CPT) code 0232T and Healthcare Common Procedure Coding System (HCPCS) code G0460. The insurer lists CPT 0232T as an injection of platelet-rich plasma at any site, including image guidance, harvesting, and preparation, while HCPCS G0460 describes autologous blood products for nondiabetic chronic wounds.
Policy 0507 names these conditions and uses as experimental, investigational, or unproven:
- Degenerative joint disease and osteoarthritis of the knee
- Epicondylitis (tennis elbow or golfer’s elbow)
- Plantar fasciitis and tendonitis
- Muscle injuries, muscle disorders, and joint capsular injuries
- Soft tissue trauma, such as tendon and ligament ruptures
- Anterior cruciate ligament (ACL) repair and total knee arthroplasty
- Fractures, including long-bone nonunion
- Persistent epithelial defects of the cornea
- Periodontal disease, dental surgery, sinus augmentation, and bone graft supplementation
- Wound healing for surgical wounds, chronic wounds, and lower extremity ulcers
Policy 0507 carries an effective date of October 15, 2025, and a next review date of October 15, 2026. The document contains an explicit administrative clause stating that a customer’s specific benefit plan document may differ from the standard coverage guidelines. If a conflict arises between standard policy language and your own plan document, your specific plan document supersedes the medical policy.
What Aetna’s Policy Bulletin Says
Aetna addresses autologous platelet preparations within its formal clinical guidelines covering tissue substitutes. Specifically, Aetna Clinical Policy Bulletin 0244, titled “Skin and Soft Tissue Substitutes”, classifies autologous blood-derived products in its list of experimental, investigational, or unproven treatments.
Within the text of Clinical Policy Bulletin 0244, Aetna groups several related autologous formulations together:
- Autologous platelet-rich plasma
- Autologous platelet gel
- Autologous platelet-derived growth factors
This policy bulletin focuses primarily on skin and soft tissue applications, wound care, and tissue grafting. We did not find joint, tendon, or hair restoration named in this bulletin. If your coverage is through Aetna, ask for the plan’s written policy on the code your clinic would bill.
What Medicare Covers: Wounds, Not Joints
Medicare’s national policy on PRP is about wounds. Under Medicare National Coverage Determination 270.3, titled “Blood-Derived Products for Chronic Non-Healing Wounds”, autologous PRP is covered for the treatment of chronic non-healing diabetic wounds. Effective April 13, 2021, Medicare covers this therapy for a duration of 20 weeks, provided that the preparation device holds clear FDA clearance for managing exuding cutaneous wounds such as diabetic ulcers.
Once that initial 20-week window concludes, further coverage determinations pass to local Medicare Administrative Contractors (MACs). For chronic non-healing wounds other than diabetic ulcers, coverage is determined by the local MACs. The national policy does not cover autologous PRP for acute surgical wounds when it is applied directly to the closed incision, or for dehiscent wounds.
National Coverage Determination 270.3 is a wound care policy and does not address joints, tendons, hair, or skin. A PRP injection for knee osteoarthritis, tendon pain, or hair thinning is not a use that national policy names, so plan to pay the clinic yourself unless Medicare or your plan confirms otherwise in writing. For more context on federal reimbursement rules for cellular care, see our guide on Medicare coverage for stem cell therapy.
Original Medicare Versus Medicare Advantage
Neither Original Medicare nor Medicare Advantage has a national policy that covers platelet-rich plasma injections for knees, shoulders, or other joints. Under 42 CFR 422.101, Medicare Advantage plans must cover every service included under Part A and Part B, while adhering to all national coverage determinations and local contractor decisions. Under the CMS-4201-F final rule, Medicare Advantage enrollees must get access to the same medically necessary care they would receive in Traditional Medicare. Because NCD 270.3 names only chronic wounds, no national rule requires a Medicare Advantage plan to cover PRP for joints.
Some local Medicare contractors have written their own non-coverage policies. For example, CGS LCD L39023 maintains an explicit non-coverage policy for musculoskeletal PRP applications in Ohio and Kentucky, while First Coast LCD L39071 designates PRP outside of NCD 270.3 as not medically reasonable and necessary in Florida. Some large Medicare Advantage insurers say they follow these determinations. Humana, for example, says it applies NCDs and LCDs to its Medicare Advantage plans, and UnitedHealthcare’s Medicare Advantage policy lists the PRP injection code CPT 0232T as non-covered.
The financial paperwork differs between the two programs even though neither has a national policy covering joint PRP. If you have Original Medicare and your physician expects a denial, the clinic may ask you to sign an Advance Beneficiary Notice of Noncoverage (Form CMS-R-131) before administering the injection. This notice tells you in advance that the clinic expects Medicare to deny the claim and shifts the potential financial liability to you. The ABN applies only to Original Medicare; Medicare Advantage plans do not use it, but they are bound by the same national and local coverage rules described above.
| Payer | Policy Document | Covered Uses | Excluded Indications | Patient Financial Liability |
|---|---|---|---|---|
| Cigna | Medical Coverage Policy 0507 | None (unproven for any indication) | Knee osteoarthritis, tendonitis, plantar fasciitis, joint disease, wounds | Expect self-pay unless your plan document says otherwise |
| Aetna | Clinical Policy Bulletin 0244 | Not stated in the bulletin | Autologous blood-derived products, including PRP and platelet gel, are listed as experimental, investigational or unproven | Expect self-pay unless your plan says otherwise |
| Medicare (CMS) | National Coverage Determination 270.3 | Chronic non-healing diabetic wounds (initial 20 weeks) | Acute surgical wounds (applied to a closed incision), dehiscent wounds | Joint, tendon, hair and skin PRP are not addressed by the national policy |
| Anthem / BCBS | Varies by plan and state; not verified here | Not verified | Not verified | Ask your plan for its written policy |
Anthem and Blue Cross Blue Shield
Anthem and independent Blue Cross Blue Shield licensee plans publish individual medical policies that vary by plan and state. This guide has not verified an Anthem-specific or Blue Cross-wide medical coverage policy for outpatient PRP injections.
You can learn more about how these commercial organizations evaluate regenerative medicine by reviewing our companion breakdown on Blue Cross Blue Shield and Anthem stem cell coverage. If you hold coverage through Anthem or a local Blue Cross affiliate, contact member services directly and request the written medical coverage policy for CPT code 0232T before scheduling your injection.
The Narrow Exception: PRP Inside a Covered Surgery
PRP used inside a covered surgery is sometimes billed as part of that procedure.
A standalone injection for arthritis, hair, or skin has no covered surgery to attach to, so it is not billed that way.
A clinic that promises to work with your insurance on a standalone joint or hair PRP injection is a red flag. Ask the clinic to explain in writing what it bills to insurance and what it bills to you.
What a PRP Course Costs When You Pay Yourself
Because standalone PRP injections are usually self-pay, here is what the prices look like. In the United States, a single PRP injection session generally costs between $400 and $2,000. Most single sessions fall around $700 to $1,200.
Most protocols call for two to four sessions, and a course typically totals $1,500 to $6,000. See our breakdown of PRP injection costs, our page on PRP for hair loss, and the cost estimator.
The evidence for PRP is mixed and varies by condition. Our PRP therapy overview and PRP vs stem cell therapy guide cover it.
Questions to Ask Before You Pay
Ask both your insurer and the clinic these questions before you pay:
- Ask your insurer for the written policy on CPT code 0232T: Call the member services number on your insurance card and request the coverage policy for CPT 0232T, which is the code for autologous platelet-rich plasma injection. Ask whether the code requires prior authorization or is considered an investigational exclusion under your specific benefit plan document.
- Ask the clinic exactly which codes it plans to bill: Find out whether the provider intends to bill your insurance carrier for any portion of the appointment. If the clinic plans to bill an office visit, ultrasound guidance, or a local joint injection code alongside your regenerative care, request that breakdown in writing.
- Verify who pays if an insurance claim is rejected: If an office agrees to submit claims on your behalf, confirm in writing whether you will be held financially responsible for the balance if the insurer denies the claim or demands a post-payment refund.
- Ask for an itemized self-pay quote: Ask for a written document detailing the total out-of-pocket cost, including physician fees, blood harvesting, centrifuge processing kits, ultrasound imaging, and follow-up examinations.
- Check the clinic: Our guide on how to vet a clinic lists what to look for.
The Bottom Line on Insurance Coverage for PRP
The written policies we reviewed do not cover PRP injections for joint pain, tendonitis, hair thinning, or facial rejuvenation. Cigna lists autologous platelet-derived growth factors as experimental, investigational, or unproven for any condition, Aetna lists autologous blood-derived products as experimental, investigational, or unproven in its tissue substitutes bulletin, and Medicare’s national policy names chronic non-healing diabetic wounds. Individual plan documents govern specific member benefits, so confirm yours in writing.
If you decide to pursue platelet-rich plasma therapy for an orthopedic or aesthetic issue, budget for paying the clinic fee yourself unless your plan confirms otherwise. See PRP injection costs to understand standard self-pay rates, and the cost estimator before you sign financial paperwork. For broader questions about coverage across regenerative medicine, consult our overview of insurance coverage for stem cells and biologics.
Frequently asked questions
Does insurance cover PRP injections?
The written policies we reviewed do not cover PRP injections for joint pain, tendon injuries, hair restoration, or cosmetic uses. Cigna's written policy lists PRP for knee osteoarthritis, tendonitis and plantar fasciitis as experimental, investigational, or unproven, and Aetna lists autologous platelet-rich plasma in its experimental, investigational, or unproven section. Plan documents can differ, so check yours before paying.
Does Anthem cover PRP injections?
Anthem and Blue Cross Blue Shield plans publish their own medical policies, which vary by plan and state. We have not verified an Anthem policy specific to PRP injections, so ask your plan for its written policy on CPT code 0232T. See how these plans treat stem cell therapy in our Blue Cross stem cell coverage guide.
Does Aetna cover PRP injections?
Aetna lists autologous blood-derived products, including autologous platelet-rich plasma and autologous platelet-derived growth factors, in the experimental, investigational, or unproven section of its clinical policy bulletin 0244. The bulletin sits in a skin and soft tissue policy, so check your own plan's written policy for the code your clinic would bill.
Does Cigna cover PRP injections?
Cigna excludes PRP injections under Medical Coverage Policy 0507, stating that autologous platelet-derived growth factors for any condition or indication are experimental, investigational, or unproven. The policy explicitly names knee osteoarthritis, tendonitis, epicondylitis, and plantar fasciitis as non-covered uses. Cigna notes that your own plan document governs your benefits if it differs from the policy.
Does Medicare cover PRP injections?
Medicare's national PRP policy, National Coverage Determination 270.3, covers autologous PRP only for chronic non-healing diabetic wounds, for an initial 20-week period when specific requirements are met. A PRP injection for knee arthritis, tendon pain, hair loss, or skin is not a use that national policy names, so expect to pay yourself. Confirm with Medicare or your plan before booking.
Does Medicare Advantage cover PRP injections?
Medicare Advantage plans generally do not cover platelet-rich plasma (PRP) injections for joints, arthritis, or musculoskeletal injuries. Under federal rules, private Medicare Advantage plans must follow the same national coverage determinations and local contractor policies in their area as Original Medicare, and the national PRP policy names only chronic non-healing wounds. If you receive an outpatient PRP injection for a joint condition, expect your Medicare Advantage plan to treat it as non-covered, leaving you responsible for the entire bill.
Will my insurance pay if the clinic bills a different code?
Probably not, and a different code does not change what the insurer's policy says about the service. Insurers that classify PRP as experimental or investigational exclude it as not medically necessary, so a claim for it is typically denied whichever code is used. Be wary of any clinic that promises to work with your insurance on a joint or cosmetic PRP injection, and ask in writing what happens if the claim is denied.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.